Introduction
Short Bowel Syndrome Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. Short Bowel Syndrome is a group of complex diseases that occurs due to malfunction of a portion of small and/or large intestine. Short bowel syndrome can lead to Crohn’s disease, injury or trauma to the small intestine. Such complications are driving the growth of the short bowel syndrome market. Additionally, increasing prescriptions of Gattex and Revestive in U.S. and Europe respectively, increasing demand for growth hormones and glutamine, are also major driving factors for the Short Bowel Syndrome Market.
On the other hand, risks associated with increased blood flow due to splanchnic perfusion after glepaglutide administration, efficacy in extensive preclinical characterization, are some of the restraining factor this Market.
Geographical Overview
At a global level, the North America region was holding the highest market share in 2019, due to the revenue generated by Gattex, increasing sedentary lifestyle, increased consumption of unhealthy and junk food, causes to intestinal disorders. Europe is leading at the second position after the North America region, due to high R&D activities, rapid approval of drugs. Whereas, Asia Pacific region is considered the fastest-growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. Key factors such as changing eating habits, huge patient pool in China and India, uncontrolled consumption of antibiotics in India, investment in R&D, are driving Short Bowel Syndrome Market in the Asia Pacific region.
?
Segmental Overview
Short Bowel Syndrome Market is segmented as per below specifications -
By Drug Type:
• GLP-2
• Growth Hormone
• Glutamine
• Others
By Distribution Channel Type:
• Hospital Pharmacies
• Retail Pharmacies
• Others
Competitor Analysis
Short Bowel Syndrome Market has presence of some of the key major players across globe which includes
• Merck KGaA
• Ardelyx, Inc.
• Emmaus Life Sciences, Inc.
• GLyPharma Therapeutics, Inc.
• Naia Pharmaceuticals, Inc.
• Nutrinia Ltd.
• OxThera
• Shire PLC
• Zealand Pharma A/S
• TAKEDA, Inc.
These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies.
By Geographical Locations:
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA
Highlights of the report
What is Short Bowel Syndrome Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation
Market size projection based on Historical & current market trends
Market share analysis and key strategies adopted by leading players
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations
Chapter 1 Research Objective
1.1 Need of the Research Report
1.2 Client Objectives
1.3 Offered Solutions
Chapter 2 Recommendations
2.1 Executive Summary
2.1.1 Market Overview
2.1.2 Competitive Insights
2.1.3 Segmental Analysis
2.1.4 Geographical Market Details
2.2 Lead Generation
2.3 Consultant
2.4 Return on Investment
Chapter 3 Research Methodology
3.1 Chromatus Database
3.2 Paid Sources
3.3 Primary Data Collection
3.3.1 Email Surveys
3.3.2 Telephonic Interviews
3.3.3 Face to Face Interviews
3.4 Secondary Data Collection
3.4.1 Annual Reports
3.4.2 Government Publications
3.4.3 Trade Data
3.4.4 Association Data
3.4.5 Research Papers/ Blogs/ News Articles
3.5 Expert Advisory Panel
3.6 Data Analytics Model
Chapter 4 Short Bowel Syndrome Market Overview
4.1 Parent Market Overview
4.2 Patent Analysis
4.3 PESTEL Analysis
4.3.1 Political
4.3.2 Economical
4.3.3 Social
4.3.4 Technological
4.3.5 Legal
4.4 SWOT Analysis
4.4.1 Strengths
4.4.2 Weakness
4.4.3 Opportunities
4.4.4 Threats
4.5 Regulations
4.6 Value Chain/ Supply Chain Analysis
4.7 Procurement & Vendor Analysis
4.8 Porters Five Analysis
4.8.1 Threat of new entrants
4.8.2 Bargaining power of suppliers
4.8.3 Bargaining power of buyers
4.8.4 Threat of substitutes
4.8.5 Competitive rivalry
Chapter 5 Regional Analysis
Global Short Bowel Syndrome Market Estimation and Forecast, 2019 - 2025 (USD Billion)
5.1 North America Market
5.1.1 U.S.
5.1.1 Canada
5.2 Europe Market
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.2.4 Spain
5.2.5 Italy
5.2.6 Russia & CIS
5.2.7 Rest of Europe
5.3 Asia Pacific Market
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 South Korea
5.3.5 ASEAN
5.3.6 Rest of Asia Pacific
5.4 Rest of the World
5.4.1 Latin America
5.4.1.1 Brazil
5.4.1.2 Argentina
5.4.1.3 Rest of Latin America
5.4.2 Middle East
5.4.3 Africa
Chapter 6 Company Profile
6.1 Merck KGaA
6.1.1 Introduction
6.1.2 Financial Overview
6.1.3 Product Portfolio
6.1.4 Recent Developments
6.1.5 SWOT Analysis
6.2 Ardelyx, Inc.
6.3 Emmaus Life Sciences, Inc.
6.4 GLyPharma Therapeutics, Inc.
6.5 Naia Pharmaceuticals, Inc.
6.6 Nutrinia Ltd.
6.7 OxThera
6.8 Shire PLC
6.9 Zealand Pharma A/S
6.10 TAKEDA, Inc.
Chapter 7 Competitor Analysis
7.1 Company Ranking
7.2 Key Innovators
7.3 Market Leader
7.4 Emerging Players
7.5 Strategic Alliances
7.6 Competitive Matrix of 10 Companies
Chapter 8 Global Short Bowel Syndrome Market by Drug Type Estimation and Forecast, 2019 - 2025 (USD Billion)
8.1 GLP-2
8.2 Growth Hormone
8.3 Glutamine
8.4 Others
Chapter 9 Global Short Bowel Syndrome Market by Distribution Channel Type Estimation and Forecast, 2019 - 2025 (USD Billion)
9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 Others
Chapter 10 Appendix
10.1 Data Sources
10.2 Abbreviations
10.3 About US
10.4 Disclaimer
10.5 Key Notes
List of Tables
Table 1 Global Short Bowel Syndrome Market, by Region, 2019 - 2025 (USD Billion)
Table 2 Global Short Bowel Syndrome Market, by Drug Type, 2019 - 2025 (USD Billion)
Table 3 Global Short Bowel Syndrome Market, by Consumption Type, 2019 - 2025 (USD Billion)
Table 4 Global Short Bowel Syndrome Market, by Distribution Type, 2019 - 2025 (USD Billion)
Table 5 North America Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 6 North America Short Bowel Syndrome Market by Drug Type 2019 - 2025 (USD Billion)
Table 7 North America Short Bowel Syndrome Market by Consumption Type 2019 - 2025 (USD Billion)
Table 8 North America Short Bowel Syndrome Market by Distribution Type 2019 - 2025 (USD Billion)
Table 9 US Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 10 Canada Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 11 Europe Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 12 Europe Short Bowel Syndrome Market by Drug Type 2019 - 2025 (USD Billion)
Table 13 Europe Short Bowel Syndrome Market by Consumption Type 2019 - 2025 (USD Billion)
Table 14 Europe Short Bowel Syndrome Market by Distribution Type 2019 - 2025 (USD Billion)
Table 15 UK Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 16 Germany Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 17 France Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 18 Spain Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 19 Italy Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 20 Russia & CIS Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 21 Rest of Europe Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 22 Asia Pacific Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 23 Asia Pacific Short Bowel Syndrome Market by Drug Type 2019 - 2025 (USD Billion)
Table 24 Asia Pacific Short Bowel Syndrome Market by Consumption Type 2019 - 2025 (USD Billion)
Table 25 Asia Pacific Short Bowel Syndrome Market by Distribution Type 2019 - 2025 (USD Billion)
Table 26 China Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 27 Japan Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 28 India Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 29 South Korea Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 30 ASEAN Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 31 Rest of Asia Pacific Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 32 Latin America Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 33 Latin America Short Bowel Syndrome Market by Drug Type 2019 - 2025 (USD Billion)
Table 34 Latin America Short Bowel Syndrome Market by Consumption Type 2019 - 2025 (USD Billion)
Table 35 Latin America Short Bowel Syndrome Market by Distribution Type 2019 - 2025 (USD Billion)
Table 36 Brazil Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 37 Argentina Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 38 Rest of Latin America Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 39 Middle East Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 40 Middle East Short Bowel Syndrome Market by Drug Type 2019 - 2025 (USD Billion)
Table 41 Middle East Short Bowel Syndrome Market by Consumption Type 2019 - 2025 (USD Billion)
Table 42 Middle East Short Bowel Syndrome Market by Distribution Type 2019 - 2025 (USD Billion)
Table 43 Africa Short Bowel Syndrome Market 2019 - 2025 (USD Billion)
Table 44 Africa Short Bowel Syndrome Market by Drug Type 2019 - 2025 (USD Billion)
Table 45 Africa Short Bowel Syndrome Market by Consumption Type 2019 - 2025 (USD Billion)
Table 46 Africa Short Bowel Syndrome Market by Distribution Type 2019 - 2025 (USD Billion)
?
List of Figures
Fig. 1 Primary Research Method
Fig. 2 Secondary Research Method
Fig. 3 Value chain analysis
Fig. 4 PESTEL Analysis
Fig. 5 SWOT Analysis
Fig. 6 Porters Five forces analysis
Fig. 7 Short Bowel Syndrome Market: Penetration & growth prospect mapping
Fig. 8 Short Bowel Syndrome Market: Competitive snapshot
Fig. 9 Short Bowel Syndrome Market: Segmental snapshot
Fig. 10 Market Overview
Fig. 11 Short Bowel Syndrome Market: Product Analysis, 2019 - 2025
Fig. 12 Short Bowel Syndrome Market: Regional Analysis, 2019 - 2025
Fig. 13 Short Bowel Syndrome Market: Competitive Matrix
Fig. 14 Short Bowel Syndrome Market: Revenue Mix